Loading...

Comparison of preferences of healthcare professionals and MS patients for attributes of disease‐modifying drugs: A best‐worst scaling

BACKGROUND: The choice between disease‐modifying drugs (DMDs) for the treatment of multiple sclerosis (MS) becomes more often a shared decision between the patient and the neurologist and MS nurse. This study aimed to assess which DMD attributes are most important for the healthcare professionals in...

Full description

Saved in:
Bibliographic Details
Published in:Health Expect
Main Authors: Kremer, Ingrid E. H., Evers, Silvia M. A. A., Jongen, Peter J., Hiligsmann, Mickaël
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2017
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750752/
https://ncbi.nlm.nih.gov/pubmed/28734004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hex.12599
Tags: Add Tag
No Tags, Be the first to tag this record!